is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
CPhI Japan has agreed with partners and key industry stakeholders to postpone the show until 14-16 April 2021 and focus on other ways in which we can support the pharma industry in the remainder of 2020, with a commitment that CPhI Japan will return stronger than ever next year.
CPhI Japan interviewed with Satofumi Kawata, Representative Director at Neopharma Japan to talk about how exhibiting at the event has helped them with expanding their business.
Japanese culture has a profound impact on decision-making and ultimately business relationships. View our tips and make sure you make the best first impression possible at CPhI Japan.
Planning on joining us at CPhI Japan? Whether you’re a visitor or exhibitor, it’s likely that you’ll have plenty of meetings to attend onsite. Read our important tips regarding Business Etiquette in Japan to be well-prepared for the show.
CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating. The show closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes. Read more to discover the latest advancement.
CPhI Japan interviewed Mr. Fujikawa, Chairman at Japan Pharmaceutical Traders' Association about the development and outlook of the Japanese pharma market.
Download our in-depth market report to discover the trends of Japan's pharma market. It also covers increased internationalisation of innovation, with a rise in acquisitions and partnerships with academia.
Japan has the world’s third largest pharma industry. Yet, for many international companies the market has not proved easy to access. Read our in-depth report to understand about the landscape, opportunities and challenges of entering the market.